Neurive
PrivateLast Round
Pre Seed
Aug 26, 2021
Est. Valuation
$6.9M
Total Funding Raised
$1.02M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Neurive operates in Healthcare & Life Sciences and is based in South Korea. Its latest recorded funding round was a Pre Seed round in August 2021.
Neurive is a healthcare startup that develops electroceuticals and digital medical treatment devices based on non-invasive vagus nerve stimulation technology for various neurological disorders.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Mental Health, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neurive Comparables
Compare Neurive with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| ZenoWell | 79% | |
| Hoolest Inc. | 79% | |
| Vagustim | 79% |
For institutional investors. Book with your work email.
Neurive Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Aug 26, 2021 | ||||
| Seed | May 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Neurive Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| SL Investment | Pre Seed |
| Magna Investment | Pre Seed, Seed |
| Korean Entrepreneurship Foundation | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 22, 2026
Monthly visitors grew 147% MoM, reaching 2.4K.
- Aug 26, 2021
$850K raised from Magna Investment and SL Investment.
For institutional investors. Book with your work email.
Neurive Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Neurive's valuation, stock price, and market status.
Is Neurive a public or private company?
Neurive is a private company.
What is the current stock price of Neurive?
Neurive is a private company, so its shares have no public market price. Caplight tracks Neurive's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neurive worth (valuation)?
Neurive's valuation is estimated at $6.9M based on funding round data.
Can I buy Neurive stock?
Neurive shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neurive's last funding round?
Neurive's most recent funding round was Pre Seed on August 26, 2021.
Who are the main investors in Neurive?
Key investors in Neurive include Magna Investment.
Will Neurive IPO soon?
No public IPO plans have been announced for Neurive.
How can I track Neurive secondary market activity?
Caplight tracks bids, offers, and trades in Neurive's shares on secondary markets.